Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I hope what Deals is saying isn't true. If a another person involved with ILNS is caught up in some kind of corruption then I think this stock would go completely down the drain. It's bad enough it's circling the drain right now. Boy do we need some news!
Im thinking about adding a little to my position here. Does anyone think we will revisit .005 or would now be the time to add
I wonder who is selling these big blocks of Intellect? Hope it isn't dilution by the company.
Don't forget about CONJUMAB A that they are looking to develop for AMD. AMD is a multibillion dollar market. Come on 2.5 cents!
I will be happy as hell if this stock would go to just 2.5 cents.
OK, Im back in this stock. I must be a glutton for abuse...lol. One quick question, has anybody been in touch with the transfer agent? I have tried calling a few times to see what the current outstanding share count is and haven't been able to get through. Just want to know how much it has gone up since May 20th.
What ever happened to RV03? Are they still trying to develop it?
Legion, Do you think there is any profit potential for people who own the stock at these levels or do you think the bone will be picked completely clean for common shareholders?
Just my opinion here but I think the best thing that can happen for everyone who still holds this stock, is for the sale of the company. Hopefully after the sale there will be some meat left on the bone for common shareholders. I really expected big things from Intellect this time last year, what a difference a year makes. GLTA
Anybody have an idea who the CEO will be? I know Maza already had a crack at it. Think he will take the reigns again?
That would be great for the longs if you are right. Like I said before, I got out of this stock last year and took a decent loss, and I do remember some of the people who are still on this board who bought shares in the 3-5 cent range. I hope for them the stock goes back up to at least that same range, but I'm sure they would all like your $1 scenario better...lol. I will watch from the sidelines GLTA
Wow! Didn't see this coming! I hope for all the longs here that the company gets bought out soon!
I wonder who is trying to buy 19 million shares?
Thanks montanus. I see they updated their projection of phase 2 trials to the second half of 2013 in that newsletter.
That news letter from Viopharma doesn't really eliminate any concerns to me about the deal. To me it seems that there has been a hold up on the phase 2 trials. It also seems to me that Viopharma holds the key to Intellect's financial troubles. I would imagine that Intellect would be due a milestone payment when Viopharma started the trials, which would give Intellect the funds to continue with their pre-clinical studies. Again, I am not bashing the company, especially since Intellect has no control over the speed at which Viopharma operates, but seeing how we are almost 5 months into the year and there has been no update from Viopharma, leads me more toward thinking that something is wrong.
Very well could be for the Lonza deal, just speculating at this point.
Stock taking a huge hit so far. Wonder if there is some bad news with the court case or the Viopharma deal.
Hi all, I got out of this stock back in September. I took a decent loss from it, but I didn't put in anymore than I could have afforded to lose. Anyway, I check in on the stock from time to time to see how it is doing, and I have to say how surprised I am to see how little has gone on with the company. Really surprised that there has been no update on the Viopharma deal that was made over a year and a half ago. I'm also surprised that there has been no update on RV03 since they started pre-clinicals a year ago. Not bashing the stock or company just completely shocked at the lack of substantial info from the company. I wish all here the best and I do think people who bought under a penny will be fine here. Good luck to you all.
Well Im out, took a haircut on this one...lol. Good luck to the rest of the longs here, I hope I regret getting out.
Legion I get the feeling you really dont hate saying "I told you so"...lol. I admit I was wrong about Bapi, I still feel it was worth the risk though. Im going to hang on to my shares and see how everything else plays out with Intellect. I'm still optimistic about the company's future and if Im wrong then I'll just sell and have a tax write off in a few years. It wouldnt be the first time I lost money on a stock and it wont be the last... anyone who plays the stock market has their hits and misses.
Well I was wrong about bapi, I wonder if they will do any prodromal studies to see if Bapi can help with AD earlier in the disease.
Pfizer announced that the non-carrier group for bapi did not meet clinical endpoints either.
http://www.google.com/url?sa=t&rct=j&q=bapineuzumab%20phase%202%20results&source=web&cd=1&ved=0CF0QFjAA&url=http%3A%2F%2Fwww.medicalnewstoday.com%2Freleases%2F116691.php&ei=zqsSUJWNFKjd0QGboIHoCQ&usg=AFQjCNEX9M-lcS_NX4DLENhNdsSkn2z-kg.
If you read this article you can clearly see that there was very little chance for the carriers to be stat sig in phase 3, however, if you look at the data for non- carriers it looks very encouraging! If this data is duplicated in the phase 3 trials then you have an approved drug! In the article it says that non-carriers make up anywhere from 40 to 70 percent of the AD population, this will bring in billions of dollars of sales for the drug. If Intellect gets this n-terminus patent and Bapi is approved for non-carriers then that would be HUGE for Intellect! I dont think some people realize how big that would be for the company! Intellect would go from a company that has no revenue stream (other then milestone payments) to a company that has tens and possibly hundreds of millions of dollars of revenue in a short time!
It didnt surprise me that the carriers didnt meet endpoints, the phase 2 data for carriers failed to meet endpoints as well. It is the non-carrier group data that I believe will be positive as they were in phase 2. It could be that pfizer wanted to get the bad news out of the way first. I still believe Bapi will be approved for non-carriers and studies will be continued to treat both carriers and non-carriers earlier on in the disease.
Well topline data for carriers did not meet endpoints for Bapi. Hopefully topline data for non-carriers will be announced soon
Thank you Bioguru, I had a feeling you knew.
We should be seeing topline data for Bapi before mid August, I believe the data will be positive and lead to FDA approval. I would love to hear some news about the n- terminus patent before topline data is released. Bioguru...do you know the patent number for the n-terminus for Intellect? Just asking because you seem to have a lot of knowledge on what is going on with the company.
I wish I knew what you know Bioguru, it seems that you are saying what you know is fact. I have to start doing some more DD, hopefully I will learn what you know.
I think the reason why is because of what you just stated...that there is a strong possibility the drug works and they dont want to let Intellect get any piece of that drug. It is really a shame the tactics being used against Intellect. Im still optimistic Intellect will prevail but it is frustrating to hear this news as I feel this will be the same route taken by JNJ, PFE,and ELN against Intellect if they receive the n-terminus patent in the US.
Seems as though Big Pharma is going to fight tooth and nail over any decision that is in favor of Intellect. If Intellect gets the n-terminus patent in the US then I can see the same thing happening to Intellect again. This news is disappointing, I was actually thinking that Intellect had already received the payment and just didnt announce it. Getting dragged into a court battle right now is not a good thing. I dont see how they will pay for these legal fees without diluting the stock for cash. I hope Im wrong about that but without any milestone payments on the horizon I just dont see where else the company will get the money.
The company has been relatively quiet on the news front for a little bit now. We should be hearing news very shortly in my opinion...Here is what I would like to hear... 1st Id like to hear they received the patent for the n-terminus and then for Bapi to have positive phase 3 data. 2nd..Id like to hear that they have completed pre clinicals with IN-01-OX2. 3rd ..Viopharma is moving 0X1 into phase 2 for FA. I believe in the next few months there will be a flurry of news with these possible 3 developments Ive mentioned. The last half of this year will be a very Interesting time for this company to say the least.
What are you talking about? The stock was up over 45% today, and I believe the stock is worth a lot more than 4 cents, thats why I own the stock. You sound like the guy they call Yogi from the Yahoo Board...is this you? If it is you, I understand why you dont like the stock, you were probably in it before the 1 for 50 R/S and you took a huge hit on your position and are pissed off. I dont blame you for being pissed, but I dont take advice from scorned investors. I am comfortable with my position in this stock and I believe the company will grow by leaps and bounds over the next 4 years. If Im wrong then I'll take the hit and go play in another sandbox, I dont invest more money then I am willing to lose. Have a good weekend
WOW! Big volume today for Intellect. Anybody know why?
The non-carrier phase 3 trials for Bapi are now complete according to clinicaltrials.gov. I suspect we will hear about topline data within the next 6-8 weeks. I sure hope Intellect gets the US patent for the n-terminus before the data is released.
The stock price sure has taken a beating this past month. Im hoping to hear some good news this month that will get the stock moving again.
I dont know the patent number for the n-terminus, I only know the c- terminus ...US8173127. Do you know the patent number?
I probably sound like a broken record but I feel it is imperative that Intellect receive the n-terminus US patent soon. If Bapi gets FDA approval and Intellect hasnt received the patent then they wont get a penny from the drug until it gets approval in Japan and China which are much smaller markets and could take a while before the drug received approval in both countries. The US patent is also key in the appeal for the n-terminus patent in Europe. We are getting so close .....man am I getting antsy..lol
Legion, you really need to start speaking your mind...lol. I already know how you feel about the company and the stock, but thanks for the input.